Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability
- PMID: 12611592
- PMCID: PMC1223408
- DOI: 10.1042/BJ20021266
Regulation of targets of mTOR (mammalian target of rapamycin) signalling by intracellular amino acid availability
Erratum in
- Biochem J. 2003 Aug 1;373(Pt 3):999
Abstract
In mammalian cells, amino acids affect the phosphorylation state and function of several proteins involved in mRNA translation that are regulated via the rapamycin-sensitive mTOR (mammalian target of rapamycin) pathway. These include ribosomal protein S6 kinase, S6K1, and eukaryotic initiation factor 4E-binding protein, 4E-BP1. Amino acids, especially branched-chain amino acids, such as leucine, promote phosphorylation of 4E-BP1 and S6K1, and permit insulin to further increase their phosphorylation. However, it is not clear whether these effects are exerted by extracellular or intracellular amino acids. Inhibition of protein synthesis is expected to increase the intracellular level of amino acids, whereas inhibiting proteolysis has the opposite effect. We show in the present study that inhibition of protein synthesis by any of several protein synthesis inhibitors tested allows insulin to regulate 4E-BP1 or S6K1 in amino-acid-deprived cells, as does the addition of amino acids to the medium. In particular, insulin activates S6K1 and promotes initiation factor complex assembly in amino-acid-deprived cells treated with protein synthesis inhibitors, but cannot do so in the absence of these compounds. Their effects occur at concentrations commensurate with their inhibition of protein synthesis and are not due to activation of stress-activated kinase cascades. Inhibition of protein breakdown (autophagy) impairs the ability of insulin to regulate 4E-BP1 or S6K1 under such conditions. These and other data presented in the current study are consistent with the idea that it is intracellular amino acid levels that regulate mTOR signalling.
Similar articles
-
L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport.Biochem J. 2000 Sep 1;350 Pt 2(Pt 2):361-8. Biochem J. 2000. PMID: 10947949 Free PMC article.
-
Regulation of cap-dependent translation by insulin-like growth factor-1 in neuronal cells.Biochem Biophys Res Commun. 2002 Mar 1;291(3):560-6. doi: 10.1006/bbrc.2002.6479. Biochem Biophys Res Commun. 2002. PMID: 11855825
-
Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.Oncogene. 2006 Nov 9;25(53):7029-40. doi: 10.1038/sj.onc.1209691. Epub 2006 May 22. Oncogene. 2006. PMID: 16715128
-
Cell hydration and mTOR-dependent signalling.Acta Physiol (Oxf). 2006 May-Jun;187(1-2):223-9. doi: 10.1111/j.1748-1716.2006.01547.x. Acta Physiol (Oxf). 2006. PMID: 16734759 Review.
-
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.Oncogene. 2000 Dec 27;19(56):6680-6. doi: 10.1038/sj.onc.1204091. Oncogene. 2000. PMID: 11426655 Review.
Cited by
-
Association between myosin heavy chain protein isoforms and intramuscular anabolic signaling following resistance exercise in trained men.Physiol Rep. 2015 Jan 27;3(1):e12268. doi: 10.14814/phy2.12268. Print 2015 Jan 1. Physiol Rep. 2015. PMID: 25626869 Free PMC article.
-
Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation.Nat Immunol. 2013 May;14(5):500-8. doi: 10.1038/ni.2556. Epub 2013 Mar 24. Nat Immunol. 2013. PMID: 23525088 Free PMC article.
-
SLC38A10 Regulate Glutamate Homeostasis and Modulate the AKT/TSC2/mTOR Pathway in Mouse Primary Cortex Cells.Front Cell Dev Biol. 2022 Apr 5;10:854397. doi: 10.3389/fcell.2022.854397. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35450293 Free PMC article.
-
Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation.Oncogene. 2010 Jul 15;29(28):4068-79. doi: 10.1038/onc.2010.177. Epub 2010 May 24. Oncogene. 2010. PMID: 20498635 Free PMC article.
-
Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation.Front Immunol. 2022 May 19;13:880262. doi: 10.3389/fimmu.2022.880262. eCollection 2022. Front Immunol. 2022. PMID: 35663990 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous